Effect of clofibrate on brain mevalonate-5-pyrophosphate decarboxylaseZAFRA, M. F; RIQUELME, S; CASTILLO, M et al.Neurochemical research. 1987, Vol 12, Num 9, pp 787-790, issn 0364-3190Article

Shifting views on lipid lowering therapyKRUMHOLZ, Harlan; HAYWARD, Rodney.BMJ (Overseas and retired doctors ed.). 2010, Vol 341, Num 7768, pp 332-333, issn 1759-2151, 2 p.Article

Biological activity of the hypolipidemic agent, N²-n-butylindazoloneHALL, I. H; WILLIAMS, W. L. JR; WYRICK, S. D et al.Journal of pharmaceutical sciences. 1984, Vol 73, Num 12, pp 1788-1791, issn 0022-3549Article

Cardiac and hepatic acyl-CoA and acylcarnitine hydrolase activities in clofibrate-fed rabbitsMOORE, K. H; SOLOMON, F. J.Comparative biochemistry and physiology. C. Comparative pharmacology. 1985, Vol 80, Num 2, pp 355-359, issn 0306-4492Article

Disposition of etofibrate, clofibric and nicotinic acid esters, and their products in dogsGARRETT, E. R; ALTMAYER, P.Journal of pharmaceutical sciences. 1985, Vol 74, Num 3, pp 295-299, issn 0022-3549Article

Hépatotoxicité des hypolipémiantsLARREY, Dominique.Hépato-gastro (Montrouge). 2004, Vol 11, Num 6, pp 407-413, issn 1253-7020, 7 p.Article

The Ebbs and Flows in the Development of Cholesterol-Lowering Drugs: Prospects for the FutureHAJHOSSEINY, R; SABIR, I; KHAVANDI, K et al.Clinical pharmacology and therapeutics. 2014, Vol 96, Num 1, pp 64-73, issn 0009-9236, 10 p.Article

Rapid determination of clofibric acid in human plasma by high-performance liquid chromatographyPAILLET, M; DOUCET, D; MERDJEAN, H et al.Journal of chromatography. 1986, Vol 375, Num 1, pp 179-183, issn 0021-9673Article

Proceedings/Fenofibrate, a third-generation fibric acid derivative, symposium, Dallas TX, November 15, 1986BROWN, W. V.The American journal of medicine. 1987, Vol 83, Num 5, issn 0002-9343, 89 p., BConference Proceedings

Distinction entre patients bons synthétiseurs et bons absorbeurs pour optimiser le traitement hypocholestérolémiant : Thérapeutique = Distinction between good synthesizer and good absorber patients to optimize cholesterol-lowering therapyRADERMECKER, Régis P; SCHEEN, André J.Revue médicale suisse. 2006, Vol 2, Num 76, pp 1910-1915, issn 1660-9379, 6 p.Article

À la découverte de l'ézétimibe = EzetimibeWATKINS, C.La Lettre du cardiologue. 2004, Num 378, pp 44-45, issn 0761-5035, 2 p.Article

Lescol, vastin : Generic name : FluvastatinMALLARKEY, G.Current therapeutics. 1996, Vol 37, Num 4, pp 81-83, issn 0311-905XArticle

Current approaches to drug therapy for the hypercholesterolemic patientWITZTUM, J. L.Circulation (New York, N.Y.). 1989, Vol 80, Num 5, pp 1101-1114, issn 0009-7322, 14 p.Article

Suitability of laboratory animals for screening anti-hyperlipidemic agentsNEELA RAJWADE; DESAI, N. K; JOSHI, V. G et al.Journal of Postgraduate Medicine (Bombay). 1989, Vol 35, Num 3, pp 162-170, issn 0022-3859, 9 p.Article

Manifestations rhumatologiques de certains médicaments : quinolone, hypolipémiants, quinidine = Rheumatologic manifestations of some drugs: quinolone, antilipemic agents, quinidineBOURGEOIS, P; VIGNERON, A.-M; KOEGER, A.-C et al.L' Actualité rhumatologique. 1990, Vol 27, pp 58-67, issn 0065-1818, 10 p.Article

Ezetimibe ameliorates cholecystosteatosisMATHUR, Abhishek; WALKER, Julia J; AL-AZZAWI, Hayder H et al.Surgery. 2007, Vol 142, Num 2, pp 228-233, issn 0039-6060, 6 p.Article

Ézétimibe : Le profil d'effets indésirables se précise = Ezetimibe adverse effectsLa Revue Prescrire. 2005, Vol 25, Num 261, issn 0247-7750, p. 350Article

Underuse of lipid-lowering drugs and factors associated with poor adherence : a real practice analysis in italyDI MARTINO, Mirko; DEGLI ESPOSTI, Luca; RUFFO, Pierfrancesco et al.European journal of clinical pharmacology. 2005, Vol 61, Num 3, pp 225-230, issn 0031-6970, 6 p.Article

Contemporary recommendations for evaluating and treating hyperlipidemiaPERRY, R. S.Clinical pharmacy. 1986, Vol 5, Num 2, pp 113-127, issn 0278-2677Article

Role of phytosterols in lipid-lowering: current perspectivesGUPTA, A. K; SAVOPOULOS, C. G; AHUJA, J et al.QJM (Oxford. 1994. Print). 2011, Vol 104, Num 4, pp 301-308, issn 1460-2725, 8 p.Article

Statins in dermatologyJOWKAR, Farideh; MOHAMMAD REZA NAMAZI.International journal of dermatology. 2010, Vol 49, Num 11, pp 1235-1243, issn 0011-9059, 9 p.Article

The Acute (Cerebro)Vascular Effects of StatinsPRINZ, Vincent; ENDRES, Matthias.Anesthesia and analgesia. 2009, Vol 109, Num 2, pp 572-584, issn 0003-2999, 13 p.Article

A peri-operative statin update for non-cardiac surgery. Part II: Statin therapy for vascular surgery and peri-operative statin trial designBICCARD, B. M.Anaesthesia. 2008, Vol 63, Num 2, pp 162-171, issn 0003-2409, 10 p.Article

Statins down underMANT, Andrea; LOWINGER, Jocelyn; HALL, Wayne et al.British journal of clinical pharmacology. 2007, Vol 63, Num 1, pp 125-127, issn 0306-5251, 3 p.Article

Mécanismes d'action des hypolipidémiants = Antilipemic agentLUC, G.La Lettre du cardiologue. 2001, Num 343, pp 33-36, issn 0761-5035Article